WHO approves emergency use of first mpox test
- The World Health Organization has approved the first diagnostic test for mpox, allowing immediate results to improve testing capabilities in outbreak-affected countries.
- This new PCR test detects mpox DNA from skin lesion swabs, eliminating previous waiting times for lab results.
- Dr. Yukiko Nakatani stated this test is a "significant milestone" for expanding testing in affected nations.
60 Articles
60 Articles
WHO lists first mpox in vitro diagnostic test under Emergency Use Listing
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
WHO approves first mpox diagnostic test for emergency use
The World Health Organization has approved an mpox diagnostic test developed by Abbott Laboratories for emergency use, which should expand access to tests in efforts to contain a growing outbreak in Africa which has infected tens of thousands of people. The Alinity m MPXV assay, which is meant for use by trained clinical laboratory personnel, is a real-time PCR test that enables the detection of monkeypox virus DNA from human skin lesion swabs. …
Coverage Details
Bias Distribution
- 35% of the sources are Center, 35% of the sources lean Right
To view factuality data please Upgrade to Premium